Micelle-engineered nanoplatforms for precision oncology
dc.authorscopusid | Ali Zarrabi / 23483174100 | |
dc.authorwosid | Ali Zarrabi / U-2602-2019 | |
dc.contributor.author | Gao, Wei | |
dc.contributor.author | Bigham, Ashkan | |
dc.contributor.author | Ghomi, Matineh | |
dc.contributor.author | Zarrabi, Ali | |
dc.contributor.author | Rabiee, Navid | |
dc.contributor.author | Saeb, Mohammad Reza | |
dc.contributor.author | Ertaş, Yavuz Nuri | |
dc.contributor.author | Goel, Arul | |
dc.contributor.author | Sharifi, Esmaeel | |
dc.contributor.author | Ashrafizadeh, Milad | |
dc.contributor.author | Sethi, Gautam | |
dc.contributor.author | Tambuwala, Murtaza M. | |
dc.contributor.author | Wang, Yuzhuo | |
dc.contributor.author | Ghaffarlou, Mohammadreza | |
dc.contributor.author | Jiao, Taiwei | |
dc.date.accessioned | 2025-04-18T10:15:17Z | |
dc.date.available | 2025-04-18T10:15:17Z | |
dc.date.issued | 2024 | |
dc.department | İstinye Üniversitesi, Mühendislik ve Doğa Bilimleri Fakültesi, Biyomedikal Mühendisliği Bölümü | |
dc.description.abstract | The alliance between nanomaterials and cancer therapy has revolutionized the treatment of tumor patients. After cardiovascular diseases, cancer is the leading cause of death, so interdisciplinary approaches should be used for the treatment of this malignant disease. Both treatment and early diagnosis of cancer are challenging. The micelles belong to lipid-based nanostructures, and they have a hydrophobic core with hydrophilic head regions. The current review article focuses on the application of micelles in cancer suppression. The micelles can provide a platform for co-delivery of non-coding RNAs and RNAi in cancer gene therapy. Both synthetic and natural | |
dc.identifier.citation | Gao, W., Bigham, A., Ghomi, M., Zarrabi, A., Rabiee, N., Saeb, M. R., ... & Jiao, T. (2024). Micelle-engineered nanoplatforms for precision oncology. Chemical Engineering Journal, 495, 153438. | |
dc.identifier.doi | 10.1016/j.cej.2024.153438 | |
dc.identifier.endpage | 29 | |
dc.identifier.issn | 1385-8947 | |
dc.identifier.issn | 1873-3212 | |
dc.identifier.scopus | 2-s2.0-85197544416 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 1 | |
dc.identifier.uri | http://dx.doi.org/10.1016/j.cej.2024.153438 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/7006 | |
dc.identifier.volume | 495 | |
dc.identifier.wos | WOS:001270754100001 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.institutionauthor | Zarrabi, Ali | |
dc.institutionauthorid | Ali Zarrabi / 0000-0003-0391-1769 | |
dc.language.iso | en | |
dc.publisher | Elsevier science | |
dc.relation.ispartof | Chemical engineering journal | |
dc.relation.publicationcategory | Diğer | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Micelles | |
dc.subject | Cancer Therapy | |
dc.subject | Cancer Diagnosis | |
dc.subject | Drug Resistance | |
dc.subject | Gene Therapy | |
dc.title | Micelle-engineered nanoplatforms for precision oncology | |
dc.type | Article |